Szemészet, 2007 (144. évfolyam, 1-4. szám)

2007-11-01 / 3. szám

144. évfolyam (2007)

4. Boisjoly H.M., Roy R., Dube I., Laughrea RA., Michaud R„

Douville R, Heebert J.: HLA-A, В and DR matching in corneal transplantation. Ophthalmology 1986; 93: 1290-7.

5. Bohringer D., Reinhard T, Duquesnoy R.J., Enczmann J., Lange R, Claas F, Sundmacher R.: Beneficial effect of the matching at the HLA-A and -B amino-acid triplet level on rejection-free clear graft survival in penetrating keratoplasty. Transplantation 2004; 77: 417-421.

6. Coster D.J., Muehlberg SM., Bartlett C.M., Esterman A.: Report from the Australian corneal graft registry 1999. Snap printing: Adelaide, 2000; 1-137.

7. Falus A., Búzás E„ Rajnavölgyi É.: Az immunológia élettani és molekuláris alapjai. Semmelweis Kiadó, Budapest 2006.

8. Fink N., Startk W.J., Maquire M.G., Stulting D., Meyer R., Foulks G., Smith R.E., Rapoza R: Effectiveness of histocompatibility matching in high-risk corneal transplantation: a summary of results from the Collaborative Corneal Transplanation Studies. Cesk Oftalmol 1994; 50: 3-12.

9. Foulks G.N., Sanfilippo F.P., Locascio J.A., 3rd MacQueen J.M., Dawson D. V: Histocompatibility testing for keratoplasty in high-risk patients. Ophtalmology 1983; 90(3): 239-244.

10. Hill J.C.: The use of cyclosporine in high risk keratoplasty. Am J Ophthalmol 1989; 107: 501-10.

11. Hopkins K.A., Maguire M.G., Fink N.E., Bias W.B.: Reproductibility of HLA-A, -B and -DR typing using peripheral blood samples: results of retyping in the collaborative corneal transplantation studies. Collaborative Corneal Transplantations Study Group (corrected). Hum Immunol 1992; 33: 122-128.

12. Khaireddin R., Wachtlin J., Hopfenmüller W, Hoffmann F: HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection. Grafe’s Arch Clin Exp Ophtalmol 2003; 241: 1020-1028.

13. Khodadoust A.A.: The allograft rejection reaction: the leading cause of late failure of clinical comeal grafts. In: Cornea graft failure (Ciba foundation Symposium). Amsterdam: Elsevier, 1937; 151-167.

14. Kühle M., Cursiefen C., Nguyen N.X., Langenbucher A., Seitz A., Wenkel H., Martus R, Naumann G.O.H.: Risk factors for comeal allograft rejection: intermediate results of a prospective normalrisk keratoplasty study . Graefe’s Archive for clinical and experimental Ophtalmology. 2002; 240: 580-584

15. Langenbucher A., Seitz B., Nguyen N.X., Naumann G O.: Comeal endothelial cell loss after nonmechanical penetrating keratoplasty depends on diagnosis: a regression analysis. Graefe’s Arch Clin Exp Ophtalmol 2002; 240: 387-392.

16. Li Q., He Y.: An immunhistochemical study of Langenhans cells, T- cells and the HLA antigen in human cornea. Yan Ke Xue Bao 1993; 9: 121-5.

17. Módis L., Tóth E., Stenszky V, Berta A.: HLA-tipizált comeák beültetésével szerzett tapasztalatok. Szemészet 2007; 144: 75-79.

18. Nguyen N.X., Seitz B„ Langenbucher A., Wenkel ff, Cursiefen C.: Klinik und Therapie der Immunreaktionen nach perforierender Normalrisiko-Keratoplastik. Klinische Augenblätter der Augenheilkunde 2004; 221: 467-472

19. No authors listed. The collaborative comeal transplantation studies research group (1992) The collaborative comeal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk comeal transplantation. Arch Ophtalmol 1992; 110: 1392- 1403.

20. Opelz G.: Effect of the maintenance immunsupressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443-446.

21. Pels E„ Van der Gaag R.: HLA-A, В, C and HLA-DR antigens and dendritic cells in fresh and organ cultured preserved corneas. Cornea 1985; 3: 321-239.

22. Pepose J.S., Benevento W.J.: Detection of HLA antigens in human epikeratophakia lenticules. Cornea 1991; 10: 105-9.

23. Pleyer U., Bertelmann E.: Differenzialdiagnose und Therapie der Transplantatabsto ung nach Keratoplastik. Klin Monatsbl Aug 2005; 222: 863-869.

24. Reinhard T, Bohringer D., Enczmann J., Kogler G., Mayweg S., Wemet P, Sundmacher R.: Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching. Eye 2004; 111 (4): 775-782.

25. Sundmacher R.: Immunreaktionen nach Keratoplastik. Klin Monatsbl Aug 1977; 171: 705-722

26. Tóth E., Stenszky V, Berta A., Módis L: A HLA-tipizálás technikája szaruhártya-átültetés esetén. Szemészet 2007; 144: 71-75.

27. Vail A., Gore S.M., Bradley B.A., Easty D.L., Rogers C.A., Armitage W.J.: Conclusions of the comeal transplant follow up study. British J Ophtal 1997; 81: 631-636.

28. Vail A., Gore S.M., Bradley B.A., Easty D.L., Rogers C.A.: Comeal graft survival and visual outcome. A multicenter Study. Corneal Transplant Follow-up Study Collaborators. Ophthalmology 1994;

101: 102-107.

29. Vail A., Gore S.M., Bradley B.A., Easty D.L., Rogers C.A.: Conclusions of the comeal transplant follow-up study. Br J Ophtalmol 1997; 87:631-636.

30. Volker-Dieben H.J., Claas F.H., Schreuder G.M., Schipper RF„ Pels E.. Persijn GG., Smits J., D’Amaro J.: Beneficial effect of HLA-DR matching on the survival of corneal allografts. Transplantation 2000; 27: 640-648.

31. Williams K.A., Sawyer M.A., White M.A., Mahmood M.I., Coster D.J.: The Australian Corneal Graft Registry. Transplant Proc 1989; 21: 3141-3144.

Levelezési cím: Dr. Antalfi Viktória Semmelweis Egyetem, Szemklinika 1083 Budapest, Tömő utca 25-29. Email: antalfiviktoria@gmail.com

HLA-A-, HLA-B-, HLA-DR-egyezés és a transzplantátum-rejekció közti összefüggés retrospektív vizsgálata...